155 related articles for article (PubMed ID: 8120401)
21. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
22. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
[TBL] [Abstract][Full Text] [Related]
23. Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response.
Vora KA; Ravetch JV; Manser T
J Immunol; 1997 Sep; 159(5):2116-24. PubMed ID: 9278297
[TBL] [Abstract][Full Text] [Related]
24. A recurrent clonotype in the spontaneous anti-IgG2a rheumatoid factor response of lpr/lpr mice.
Hande S; Jacobson BA; Manser T
J Immunol; 1996 Mar; 156(5):1856-64. PubMed ID: 8596037
[TBL] [Abstract][Full Text] [Related]
25. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
[TBL] [Abstract][Full Text] [Related]
26. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
[TBL] [Abstract][Full Text] [Related]
27. Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope.
Mockridge CI; Chapman CJ; Spellerberg MB; Isenberg DA; Stevenson FK
J Immunol; 1996 Sep; 157(6):2449-54. PubMed ID: 8805644
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors.
Yachimovich-Cohen N; Fischel R; Bachar N; Yarkoni Y; Eilat D
Eur J Immunol; 2003 Sep; 33(9):2469-78. PubMed ID: 12938223
[TBL] [Abstract][Full Text] [Related]
30. The site and stage of anti-DNA B-cell deletion.
Chen C; Nagy Z; Radic MZ; Hardy RR; Huszar D; Camper SA; Weigert M
Nature; 1995 Jan; 373(6511):252-5. PubMed ID: 7816141
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing.
Chen C; Nagy Z; Prak EL; Weigert M
Immunity; 1995 Dec; 3(6):747-55. PubMed ID: 8777720
[TBL] [Abstract][Full Text] [Related]
32. Characterization of anti-DNA B cells that escape negative selection.
Bynoe MS; Spatz L; Diamond B
Eur J Immunol; 1999 Apr; 29(4):1304-13. PubMed ID: 10229098
[TBL] [Abstract][Full Text] [Related]
33. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern.
Li Y; Li H; Ni D; Weigert M
J Exp Med; 2002 Dec; 196(12):1543-52. PubMed ID: 12486097
[TBL] [Abstract][Full Text] [Related]
34. Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene.
Steeves MA; Marion TN
J Immunol; 2004 Jun; 172(11):6568-77. PubMed ID: 15153471
[TBL] [Abstract][Full Text] [Related]
35. Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease.
Radic MZ; Ibrahim SM; Rauch J; Camper SA; Weigert M
J Immunol; 1995 Sep; 155(6):3213-22. PubMed ID: 7673734
[TBL] [Abstract][Full Text] [Related]
36. Chromatin specificity of anti-double-stranded DNA antibodies and a role for Arg residues in the third complementarity-determining region of the heavy chain.
Guth AM; Zhang X; Smith D; Detanico T; Wysocki LJ
J Immunol; 2003 Dec; 171(11):6260-6. PubMed ID: 14634143
[TBL] [Abstract][Full Text] [Related]
37. The expressed heavy chain V gene repertoire of circulating B cells in normal adults.
Stollar BD
Ann N Y Acad Sci; 1995 Sep; 764():265-74. PubMed ID: 7486534
[No Abstract] [Full Text] [Related]
38. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells.
Sekiguchi DR; Eisenberg RA; Weigert M
J Exp Med; 2003 Jan; 197(1):27-39. PubMed ID: 12515811
[TBL] [Abstract][Full Text] [Related]
39. Prolactin modulates the naive B cell repertoire.
Peeva E; Michael D; Cleary J; Rice J; Chen X; Diamond B
J Clin Invest; 2003 Jan; 111(2):275-83. PubMed ID: 12531884
[TBL] [Abstract][Full Text] [Related]
40. Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay D; Saunders T; Camper S; Weigert M
J Exp Med; 1993 Apr; 177(4):999-1008. PubMed ID: 8459227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
